| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Neil Woodford | Q6989497 |
| David M. Livermore | Q100272320 | ||
| P433 | issue | 9 | |
| P921 | main subject | Enterobacteriaceae | Q380136 |
| P304 | page(s) | 413-420 | |
| P577 | publication date | 2006-07-31 | |
| P1433 | published in | Trends in Microbiology | Q15265732 |
| P1476 | title | The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter | |
| P478 | volume | 14 |
| Q34746620 | A Rare Case of Prosthetic Valve Endocarditis Caused by Extended-spectrum β-Lactamase Producing Escherichia coli |
| Q54291463 | A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates. |
| Q48277891 | AIM-1: An Antibiotic-Degrading Metallohydrolase That Displays Mechanistic Flexibility. |
| Q45945780 | Acinetobacter baumannii: emergence of four strains with novel bla(OXA-51-like) genes in patients with diabetes mellitus. |
| Q41870610 | Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae |
| Q37366249 | AmpC beta-lactamases |
| Q28257612 | An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii |
| Q36667925 | An overview of harms associated with beta-lactam antimicrobials: where do the carbapenems fit in? |
| Q36957896 | Analysis of the 16S-23S rRNA gene internal transcribed spacer region in Klebsiella species |
| Q27670891 | Analysis of the Binding Forces Driving the Tight Interactions between -Lactamase Inhibitory Protein-II (BLIP-II) and Class A -Lactamases |
| Q28603769 | Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa |
| Q35007624 | Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms |
| Q37025045 | Antibiotics in urology: new essentials |
| Q40468348 | Antimicrobial resistance and beta-lactamase production of Escherichia coli causing canine urinary tract infections: Passive surveillance of laboratory isolates in Saskatoon, Canada, 2014. |
| Q38118080 | Antimicrobial resistance in the food chain: a review |
| Q36156698 | Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa |
| Q33958554 | Approaches to the simultaneous inactivation of metallo- and serine-beta-lactamases |
| Q26783911 | Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis |
| Q41072200 | Association between Virulence Factors and Extended Spectrum Beta-Lactamase Producing Klebsiella pneumoniae Compared to Nonproducing Isolates. |
| Q41440519 | BLIP-II is a highly potent inhibitor of Klebsiella pneumoniae carbapenemase (KPC-2). |
| Q29616084 | Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America |
| Q43195342 | Beta-lactam resistance in variants of Aeromonas spp. selected in vitro under antibiotic pressure |
| Q37514259 | Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update |
| Q26795565 | Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria |
| Q40362864 | Carbapenem Resistance in Non-Fermentative Bacterial Species and in Enterobacteriaceae Isolates from Hospitalized Patients in Different Health-Care Settings. |
| Q28078775 | Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia |
| Q43251112 | Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium |
| Q39843388 | Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities |
| Q89220229 | Carbapenem-resistant Gram-negative bacteria associated with catheter-related bloodstream infections in three intensive care units in Egypt |
| Q33966781 | Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry |
| Q42337336 | Carbapenemase-Producing Enterobacteriaceae Isolates from Edo State, Nigeria. |
| Q24685034 | Carbapenemases: the versatile beta-lactamases |
| Q28493086 | Catalytic spectrum of the penicillin-binding protein 4 of Pseudomonas aeruginosa, a nexus for the induction of β-lactam antibiotic resistance |
| Q38985065 | Ceftazidime-avibactam for the treatment of complicated intra-abdominal infections |
| Q34325573 | Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination |
| Q34402134 | Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections. |
| Q38740494 | Ceftazidime-avibactam: novel antimicrobial combination for the treatment of complicated urinary tract infections |
| Q42037165 | Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. |
| Q48047946 | Characterization and purification of a bacteriocin from Lactobacillus paracasei subsp. paracasei BMK2005, an intestinal isolate active against multidrug-resistant pathogens |
| Q36278614 | Characterization of CTX-M-Type Extend-Spectrum β-Lactamase Producing Klebsiella spp. in Kashan, Iran. |
| Q91869301 | Chronic nail biting, orthodontic treatment and Enterobacteriaceae in the oral cavity |
| Q35562890 | Classification of Beta-lactamases and penicillin binding proteins using ligand-centric network models |
| Q36482801 | Clinical and economic impact of common multidrug-resistant gram-negative bacilli |
| Q38712168 | Clonal Diversity of ESBL-Producing Escherichia coli Isolated from Environmental, Human and Food Samples. |
| Q36314596 | Clonal spread of imipenem-resistant Acinetobacter baumannii among different cities of China |
| Q41824709 | Comparative analysis of the complete genome of KPC-2-producing Klebsiella pneumoniae Kp13 reveals remarkable genome plasticity and a wide repertoire of virulence and resistance mechanisms |
| Q33676256 | Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates |
| Q37083119 | Comparison of Antimicrobial Resistance in Escherichia coli Strains Isolated From Healthy Poultry and Swine Farm Workers Using Antibiotics in Korea |
| Q35867403 | Complete sequence of a novel 178-kilobase plasmid carrying bla(NDM-1) in a Providencia stuartii strain isolated in Afghanistan. |
| Q26741962 | Cryptic prophages as targets for drug development |
| Q36960068 | Current concepts in antibiotic-resistant gram-negative bacteria |
| Q30575523 | Current data and trends about the resistance of Gram-negative pathogens to beta-lactams |
| Q42799124 | Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures |
| Q38724072 | Detection of genes mediating beta-lactamase production in isolates of enterobacteria recovered from wild pets in Saudi Arabia |
| Q92502755 | Development and Evaluation of a Novel Protein-Based Assay for Specific Detection of KPC β-Lactamases from Klebsiella pneumoniae Clinical Isolates |
| Q44654345 | Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece |
| Q46286684 | Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens. |
| Q40075817 | Draft Genome Sequence of blaNDM-1-Positive Escherichia coli O25b-ST131 Clone Isolated from an Environmental Sample. |
| Q43228810 | Ecological effects of selective decontamination on resistant gram-negative bacterial colonization |
| Q43045719 | Efficacy of a Ceftazidime-Avibactam combination in a murine model of Septicemia caused by Enterobacteriaceae species producing ampc or extended-spectrum β-lactamases |
| Q24609407 | Efflux-mediated drug resistance in bacteria: an update |
| Q42783458 | Emergence of Escherichia coli, Co-Producing NDM-1 and OXA-48 Carbapenemases, in Urinary Isolates, at a Tertiary Care Centre at Central India |
| Q21134613 | Enhancing the antibiotic antibacterial effect by sub lethal tellurite concentrations: tellurite and cefotaxime act synergistically in Escherichia coli |
| Q41339701 | Epidemiology of extensive drug resistant Acinetobacter baumannii (XDRAB) at Security Forces Hospital (SFH) in Kingdom of Saudi Arabia (KSA). |
| Q92647767 | Evaluation and entomopathogenicity of gut bacteria associated with dauer juveniles of Oscheius chongmingensis (Nematoda: Rhabditidae) |
| Q42555263 | Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory |
| Q33893632 | Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems |
| Q82796919 | Expression of ESBL-like activity in infrequently encountered members of the family Enterobacteriaceae |
| Q35637003 | Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Enterobacteriaceae Isolated from Egyptian Patients with Suspected Blood Stream Infection. |
| Q38191750 | Extended-spectrum β-lactamase, carbapenemase and AmpC producing Enterobacteriaceae in companion animals. |
| Q35681590 | Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance |
| Q38063968 | Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment |
| Q92297960 | FALSE POSITIVE PHENOTYPIC DETECTION OF METALLO-BETA-LACTAMASES IN ACINETOBACTER BAUMANNII |
| Q39409432 | Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and Shiga toxin-producing Escherichia coli in asymptomatic nursery children in Lower Saxony (Germany), 2014. |
| Q34096605 | Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. |
| Q39539387 | Gene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculation. |
| Q38863458 | Genetic analysis of antimicrobial resistance in Escherichia coli isolated from diarrheic neonatal calves. |
| Q38863446 | Genetic analysis of multiple antimicrobial resistance in Salmonella isolated from diseased broilers in Egypt. |
| Q36949522 | Genetic structure associated with blaOXA-18, encoding a clavulanic acid-inhibited extended-spectrum oxacillinase |
| Q34007844 | Genomic analysis and temperature-dependent transcriptome profiles of the rhizosphere originating strain Pseudomonas aeruginosa M18. |
| Q36969763 | Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization |
| Q35843094 | High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update. |
| Q41886610 | Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media |
| Q93386581 | Identification, molecular characterization, and structural analysis of the blaNDM-1 gene/enzyme from NDM-1-producing Klebsiella pneumoniae isolates |
| Q60049273 | In silico identification and experimental validation of hits active against KPC-2 β-lactamase |
| Q42111112 | In vitro and in vivo properties of BAL30376, a β-lactam and dual beta-lactamase inhibitor combination with enhanced activity against Gram-negative Bacilli that express multiple β-lactamases |
| Q40751280 | In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli |
| Q40119566 | Induction of β-Lactamase Activity and Decreased β-Lactam Susceptibility by CO2 in Clinical Bacterial Isolates |
| Q38624963 | Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE). |
| Q27651899 | Inhibition of Class A β-Lactamases by Carbapenems: Crystallographic Observation of Two Conformations of Meropenem in SHV-1 |
| Q40063537 | Inhibition of New Delhi Metallo-β-Lactamase 1 (NDM-1) Producing Escherichia coli IR-6 by Selected Plant Extracts and Their Synergistic Actions with Antibiotics. |
| Q33606363 | Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design |
| Q37557841 | Intra-abdominal infections: etiology, epidemiology, microbiological diagnosis and antibiotic resistance. |
| Q36894452 | Introduction: the challenge of multiresistance |
| Q36427124 | Isolation and Genetic Analysis of Multidrug Resistant Bacteria from Diabetic Foot Ulcers |
| Q104473849 | Isolation and molecular characterization of multidrug-resistant Escherichia coli from chicken meat |
| Q37477915 | Isolation and molecular characterization of multidrug-resistant Gram-negative bacteria from imported flamingos in Japan |
| Q47147679 | Joint Opinion on antimicrobial resistance (AMR) focused on zoonotic infections |
| Q41641131 | Laboratory detection of Enterobacteriaceae that produce carbapenemases |
| Q38060809 | Metallo-β-lactamase structure and function |
| Q40105032 | Metallo-β-lactamase-producing clinical isolates from patients of a tertiary care hospital |
| Q58762159 | Molecular characterization of Carbapenem resistant Escherichia coli recovered from a tertiary hospital in Lebanon |
| Q52801384 | Molecular characterization of ESBL-producing Enterobacteriaceae in northern Portugal. |
| Q33876665 | Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan |
| Q33711902 | Multidrug resistant Acinetobacter |
| Q37656243 | Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy |
| Q34548635 | Multiple Global Suppressors of Protein Stability Defects Facilitate the Evolution of Extended-Spectrum TEM β-Lactamases |
| Q37291349 | Multiresistant Enterobacteriaceae: new threat of an old problem |
| Q42946338 | National Surveillance of Antimicrobial Susceptibility of CTX-M-positive and -Negative Clinical Isolates ofEscherichia colifrom Kuwait Government Hospitals |
| Q28547682 | Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability |
| Q26741342 | New Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including Biofilms |
| Q36895636 | New beta-lactamases: a paradigm for the rapid response of bacterial evolution in the clinical setting |
| Q36894462 | Non-fermentative Gram-negative bacteria |
| Q46136762 | Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06. |
| Q37324603 | Novel approaches to discovery of antibacterial agents |
| Q33783917 | Ordering the mob: Insights into replicon and MOB typing schemes from analysis of a curated dataset of publicly available plasmids |
| Q47769461 | Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective. |
| Q34045418 | Pharmacokinetics and safety of CXA-101, a new antipseudomonal cephalosporin, in healthy adult male and female subjects receiving single- and multiple-dose intravenous infusions |
| Q47923627 | Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor |
| Q64890206 | Phenotypic & genotypic profile of antimicrobial resistance in Pseudomonas species in hospitalized patients. |
| Q50093207 | Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC-2: A Step against Bacterial Resistance. |
| Q42446704 | Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium |
| Q40102728 | Plasmid-mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical isolates from the Western Cape region of South Africa |
| Q34694926 | Platforms for antibiotic discovery |
| Q41974370 | Potency and spectrum of activity of AN3365, a novel boron-containing protein synthesis inhibitor, tested against clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli |
| Q40616155 | Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae. |
| Q41700834 | Prevalence and Antibiotic Susceptibility Patterns of Extended-Spectrum ß-Lactamase and Metallo-ß-Lactamase-Producing Uropathogenic Escherichia coli Isolates |
| Q55365818 | Prevalence and antimicrobial susceptibility patterns of extended spectrum beta-lactamase producing Entrobacteriaceae in the University of Gondar Referral Hospital environments, northwest Ethiopia. |
| Q36949536 | Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experience |
| Q51798794 | Prevalence characterization of extended-spectrum beta-lactamases among Escherichia coli isolates collected in Zhengzhou. |
| Q37155715 | Prevalence of Antibiotic Resistance in Escherichia coli Fecal Isolates From Healthy Persons and Patients With Diarrhea |
| Q43044341 | Prevalence of fecal carriage of acquired expanded-spectrum cephalosporin resistance in Enterobacteriaceae strains from cattle in France |
| Q27001490 | Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections |
| Q37207449 | Purification, crystallization and preliminary X-ray analysis of the beta-lactamase Oih-1 from Oceanobacillus iheyensis |
| Q58998538 | Resistance of Gram-Negative Bacilli in Lebanon |
| Q93090452 | Risk factors for acquisition of carbapenem-resistance during treatment with carbapenem in the intensive care unit: a prospective study |
| Q47147789 | Scientific Opinion on the maintenance of the list of QPS microorganisms intentionally added to food or feed (2009 update) |
| Q47150482 | Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals |
| Q35684566 | Sequence analysis of genes mediating extended-spectrum beta-lactamase (ESBL) production in isolates of Enterobacteriaceae in a Lagos Teaching Hospital, Nigeria |
| Q35912785 | Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae. |
| Q28476193 | Statistical metamodeling for revealing synergistic antimicrobial interactions |
| Q27657721 | Structural and Biochemical Evidence That a TEM-1 -Lactamase N170G Active Site Mutant Acts via Substrate-assisted Catalysis |
| Q52661545 | Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases. |
| Q27666516 | Structures of the Class D Carbapenemase OXA-24 from Acinetobacter baumannii in Complex with Doripenem |
| Q36505545 | Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America |
| Q36286719 | Suspicion of respiratory tract infection with multidrug-resistant Enterobacteriaceae: epidemiology and risk factors from a Paediatric Intensive Care Unit |
| Q57056883 | Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance |
| Q30393531 | Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics |
| Q38842620 | Tackling Threats and Future Problems of Multidrug-Resistant Bacteria |
| Q48544038 | Tackling antibiotic resistance: the environmental framework |
| Q82536176 | The First Case of Multidrug-resistant NDM-1-harboring Enterobacteriaceae in Taiwan: Here Comes the Superbacteria! |
| Q92256044 | The Occurrence and Characterization of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Isolated from Clinical Diagnostic Specimens of Equine Origin |
| Q43168377 | The characteristics of VIM-1-producing Klebsiella pneumoniae from South Africa |
| Q35689231 | The class A β-lactamase FTU-1 is native to Francisella tularensis |
| Q37069191 | The current state of multidrug-resistant gram-negative bacilli in North America |
| Q30371239 | The growing burden of antimicrobial resistance. |
| Q33634460 | The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea |
| Q54381136 | The latest threat in the war on antimicrobial resistance. |
| Q57171280 | The rise of neutron cryo-crystallography |
| Q37169849 | The role of carbapenems in initial therapy for serious Gram-negative infections |
| Q38017141 | The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae |
| Q34167642 | The sentinel role of peptidoglycan recycling in the β-lactam resistance of the Gram-negative Enterobacteriaceae and Pseudomonas aeruginosa. |
| Q44861486 | The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis |
| Q37203095 | The use of platensimycin and platencin to fight antibiotic resistance |
| Q36866216 | Therapeutic applications of tigecycline in the management of complicated skin and skin structure infections |
| Q34803735 | Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies |
| Q37713699 | Travel-related carbapenemase-producing Gram-negative bacteria in Alberta, Canada: the first 3 years |
| Q33419727 | Uncovering new signaling proteins and potential drug targets through the interactome analysis of Mycobacterium tuberculosis |
| Q37144843 | Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis |
| Q46854984 | Virulence and extended-spectrum β-lactamase encoding genes in Escherichia coli recovered from chicken meat intended for hospitalized human consumption. |
| Q48632952 | Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms |
| Q21266682 | Whole-genome sequencing and identification of Morganella morganii KT pathogenicity-related genes |
| Q34529063 | rmtD2, a new allele of a 16S rRNA methylase gene, has been present in Enterobacteriaceae isolates from Argentina for more than a decade. |
| Q86933410 | β-Lactam antibiotic-degrading enzymes from non-pathogenic marine organisms: a potential threat to human health |
Search more.